Search for: "Watson v. Johnson " Results 81 - 100 of 122
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 May 2010, 9:10 pm by cdw
Watson, No. 08-6261 (5/24/2010) Dismissed as improvidently granted Renico v. [read post]
6 Mar 2010, 1:16 pm by Anna Christensen
  To the case page for Johnson v. [read post]
4 Feb 2010, 4:24 pm by Don Cruse
The only dissent disagreed with the Court’s denial of review — which is not a decision on the merits — in Watson v. [read post]
18 Jan 2010, 8:18 pm by cdw
In what some may call a blistering assault on the trial prosecutor, the Florida Supreme Court in Paul Beasley Johnson v. [read post]
15 Jan 2010, 10:11 am by Chuck Ramsay
Jakway, Thomas Petros, Christopher Azarian, Martin Johnson, Calvin Pineo, Gordie Bader, Michael Johnson, Denise Plunkett, Thomas C. … [read post]
31 Dec 2009, 4:40 pm by Tom Goldstein
Quon Docket: 08-1332 Argument date: Will be set for argument in March or April 2010 Question presented: Does the Constitution prevent the government from reviewing text messages sent by an employee on a government device. ------- Criminal Law ------- Title: Johnson v. [read post]
24 Dec 2009, 6:20 am by Jon L. Gelman
Grace - Yes Stender, Linda - Yes Thompson, Samuel D. - Yes Tucker, Cleopatra G. - Yes Vainieri Huttle, Valerie - Yes Van Pelt, Daniel M. - Yes Vandervalk, Charlotte - Yes Vas, Joseph - Not Voting Voss, Joan M. - Yes Wagner, Connie - Yes Watson Coleman, Bonnie - Yes Webber, Jay - Yes Wisniewski, John S. - Yes Wolfe, David W. - Yes ......... [read post]
16 Sep 2009, 1:47 pm
(Springfield, MA; Diane Johnson, President) Blue Marble Group Inc. [read post]
29 Jul 2009, 6:45 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Tri-Cyclen Lo (Norgestimate, Ethinyl estradiol) – US: Johnson & Johnson, Teva settle patent infringement proceedings – the reverse of a reverse payment? [read post]
17 Jun 2009, 3:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Gene patenting debate continues: UCLA v USPTO (Patent Docs) (Patent Docs) (PatentlyBIOtech) (Patent Docs) (IP Watchdog) US: FTC issues highly anticipated report on follow-on biologics; report concludes that special legislative exclusivity incentives are largely unwarranted for innovators and generics (FDA Law Blog) (Patent Docs) (Patent… [read post]
17 Jun 2009, 3:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: Gene patenting debate continues: UCLA v USPTO (Patent Docs) (Patent Docs) (PatentlyBIOtech) (Patent Docs) (IP Watchdog) US: FTC issues highly anticipated report on follow-on biologics; report concludes that special legislative exclusivity incentives are largely unwarranted for innovators and generics (FDA Law Blog) (Patent Docs)… [read post]
1 May 2009, 9:00 am
(IAM) US: Johnson & Johnson – 5 year exclusivity period would kill incentives to innovate (Patent Docs) US: CHI CEO on patent reform and follow-on biologics legislation (Patent Docs) US: BIO urges Congress on patent reform: First, do no harm (Patent Baristas) US: Pharmaceutical advertising: How to use a domain name to circumvent application of law (Domain Name / Nom De Domaine!) [read post]